High prevalence of polycystic ovary syndrome characteristics in girls with euthyroid chronic lymphocytic thyroiditis: A case-control study

European Journal of Endocrinology

Volumn 162, Issue 6, 2010, Pages 1117-1122

  Ganie, Mohd Ashraf ^b   Marwaha, Raman Kumar ^a   Aggarwal, Rashmi ^a   Singh, Satveer ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; BODY MASS; CASE CONTROL STUDY; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EUTHYROID CHRONIC LYMPHOCYTIC THYROIDITIS; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; LYMPHOCYTIC THYROIDITIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PHENOTYPE; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADOLESCENT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; FOLLICLE STIMULATING HORMONE; GLUCOSE TOLERANCE TEST; HASHIMOTO DISEASE; HUMANS; INSULIN; INSULIN RESISTANCE; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PREVALENCE; TESTOSTERONE;

EID: 77952677939     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1012     Document Type: Article

References (28)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli C, Spina GG, Zapanti ED & Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism 1999 84 4006-4011. (Pubitemid 30644187)
2. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S & Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism 2000 85 2434-2438. (Pubitemid 32269197)
3. Stein IF & Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology 1935 29 181-191.
4. Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 1997 18 774-800. (Pubitemid 28009567)
5. Goodarzi MO & Korenman SG. The importance of insulin resistance in polycystic ovary syndrome. Fertility and Sterility 2003 80 255-258. (Pubitemid 36959775)
6. Kulshreshtha B, Ganie MA, Praveen EP, Gupta N, Khurana ML, Seith A, Dwivedi SN, Kumar G & Ammini AC. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Gynecological Endocrinology 2008 24 637-643.
7. Nieuwenhuis-Ruifrok AE, Kuchenbecker WK, Hoek A, Middleton P & Norman RJ. Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis. Human Reproduction Update 2009 15 57-68.
8. Ganie MA, Khurana ML, Eunice M, Gupta N, Gulati M, Dwivedi SN & Ammini AC. Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study. Journal of Clinical Endocrinology and Metabolism 2004 89 2756-2762. (Pubitemid 38766362)
9. Tarkun I, Cetinarslan B, Türemen E, Cantürk Z & Biyikli M. Association between circulating tumor necrosis factor-alpha, interleukin-6, and insulin resistance in low grade inflammatory serum markers in patients with polycystic ovary syndrome (PCOS) and their relationship to PPAR gamma gene variants. Experimental and Clinical Endocrinology & Diabetes 2008 116 481-486.
10. Jakubowska J, Bohdanowicz-Pawlak A, Milewicz A, Szymczak J, Bednarek-Tupikowska G & Demissie M. Plasma cytokines in obese women with polycystic ovary syndrome, before and after metformin treatment. Gynecological Endocrinology 2008 24 378-384. (Pubitemid 352032225)
11. Janssen OE, Mehlmauer N, Hahn S, Offner AH & Gärtner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. European Journal of Endocrinology 2004 150 363-369. (Pubitemid 38443788)
12. Idris I & O'Malley BP. Thyrotoxicosis in Down's and Turner's syndromes: the likelihood of Hashimoto's thyroiditis as the underlying etiology. International Journal of Clinical Practice 2000 54 272-273. (Pubitemid 30319219)
13. Marwaha RK, Sen S, Tandon N, Sahoo M, Walia RP, Singh S, Ganguly SK & Jain SK. Familial aggregation of autoimmune thyroiditis in first degree relatives of patients with juvenile autoimmune thyroid disease. Thyroid 2003 13 299-302.
14. Kanga U, Tandon N, Marwaha RK, Goswami D, Gupta N, Ray D & Mehra NK. Immunogenetic association and thyroid autoantibodies in juvenile autoimmune thyroiditis in North India. Clinical Endocrinology 2006 64 573-579.
15. Crosignani PG & Nicolosi AE. Polycystic ovarian disease: heritability and heterogeneity. Human Reproduction Update 2001 7 3-7.
16. Franks S, Gharani N & McCarthy M. Candidate genes in polycystic ovary syndrome. Human Reproduction Update 2001 7 405-410. (Pubitemid 32655326)
17. Urbanek M, Legro RS, Driscoll DA, Azziz R, Ehrmann DA & Norman RJ. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. PNAS 1999 96 8573-8578.
18. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 2004 19 41-47.
19. Ferriman D & Gallwey JD. Clinical assessment of body hair growth in women. Journal of Clinical Endocrinology and Metabolism 1961 21 1440-1447.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment (HOMA): insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
21. Diamanti-Kandarakis E. PCOS in adolescents. Best Practice & Research. Clinical Obstetrics & Gynaecology 2010 24 173-183.
22. Sultan C & Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertility and Sterility 2006 86 S6.
23. Marwaha RK, Tandon N, Karak AK, Gupta N, Verma K & Kochupillai N. Hashimoto's thyroiditis: countrywide screening of Goitrous healthy young girls in post-iodization phase in India. Journal of Clinical Endocrinology and Metabolism 2000 85 3798-3802.
24. Hefler-Frischmuth K, Walch K, Huebl W, Baumuehlner K, Tempfer C & Hefler L. Serologic markers of autoimmunity in women with the polycystic ovary syndrome. Fertility and Sterility 2009 92 e59-e60.
25. Van Gelderen CJ & Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. Journal of Reproductive Medicine 1993 38 381-386.
26. Fenichel P, Gobert B, Carre Y, Barbarino-Monnier P & Hieronimus S. Polycystic ovary syndrome in autoimmune disease. Lancet 1999 353 2210.
27. Gambineri A, Pelusi C, Vicennati V, Pagotto U & Pasquali R. Obesity and the polycystic ovary syndrome. International Journal of Obesity and Related Metabolic Disorders 2002 26 883-896.
28. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B & Straub RH. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004 13 635-638.